Skip to content

Diagnosing expiratory flow limitation in COPD patietns with forced oscillation technique using linear regression in the time frequency domain

Diagnosing expiratory flow limitation in COPD patietns with forced oscillation technique using linear regression in the time frequency domain - FOT and EFL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29991
Enrollment
60
Registered
2006-10-11
Start date
2006-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung emfysema chronic bronchitis

Interventions

None listed

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients should meet the standard diagnostic criteria for COPD and they are current or ex-smokers. The subjects must have stable disease at the time of the inclusion, which means that they cannot have an exacerbation of the COPD during the 4 weeks previous to the inclusion

Exclusion criteria

Exclusion criteria: History of exacerbation of COPD in the preceding month Upper airway obstruction Allergic Asthma OSAS Extreme obesity (BMI>35) Pulmonary disease other than COPD Clinically manifest cardiac disease (for example clinically relevant congestive heart failure, unstable angina pectoris)

Design outcomes

Primary

MeasureTime frame
Xrs-8 (cmH20.s/L) (shorthand notation for the most negative value of Xrs during expiration at 8 Hz) Open or closed loop in pressure-volume loop measured by the body plethysmography

Secondary

MeasureTime frame
Spirometry: FEV1 (L), FVC (L), IC (L), VC max (L), CO-diffusion: TLCOSB, kCO Body plethysmography: RV (L) TLC (L) Forced oscillation technique: Xrs-12,16,20,24 (cmH20.s/L) Rrs-8,12,16,20,24 (cmH20.s/L) Phase-8,12,16,20,24 (degrees) Amplitude-8,12,16,20,24 (cmH20.s/L) Other study parameters Anthropometrical data

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)